Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Kiyotaka Fujii Appointed President and Chief Executive Officer of Quintiles Japan

   Succeeds Derek Winstanly, who takes on global role in strategic customer
                                relationships

    RESEARCH TRIANGLE PARK, N.C., July 21 /PRNewswire/ -- Quintiles
Transnational Corp. today announced the appointment of Kiyotaka Fujii as
President and Chief Executive Officer of Quintiles Transnational Japan K.K.
(Quintiles Japan) as of August 1, 2005.
    An executive with more than 20 years of international business experience,
Fujii will lead all operations of Quintiles Japan.  With approximately 1,800
employees, Quintiles Japan is the largest provider of development, commercial
and financial solutions to pharma and biotech companies operating in Japan,
the world's second-largest pharmaceutical market.
    Prior to joining Quintiles, Fujii was President and CEO of SAP Japan Co.,
Ltd.  SAP is the world's largest enterprise software company.  Under Fujii's
leadership since 2000, SAP Japan has grown its business threefold, with now
over 50% market share.
    Fujii, 48, will report to Quintiles Transnational Chairman and CEO Dennis
Gillings, CBE, and will become a member of the Quintiles Transnational
Executive Committee.  He succeeds Derek Winstanly, M.D., who has taken a new
role within Quintiles Transnational as Executive Vice President, Strategic
Customer Relationships and Business Partnerships.  Winstanly will continue to
report to Gillings and remains on the Quintiles Japan Board.
    "Over the past six years Dr. Winstanly has led Quintiles Japan's most
vigorous periods of growth and expansion," Gillings said.  "He now will use
his talent and expertise at a global level in helping pharma companies use
Quintiles' capabilities to solve major challenges, such as pricing pressures,
slow product development and realizing greater value from marketing
expenditures.
    "We are very fortunate to have Kiyotaka Fujii succeed Dr. Winstanly as
head of Quintiles Japan.  Throughout his career, Fujii has demonstrated strong
leadership and the ability to think strategically while delivering operational
excellence and financial growth.
    "Quintiles Japan is well positioned for another period of rapid growth.
We have an unmatched array of services in product development and
commercialization.  I believe Fujii's organizational and leadership abilities
will help raise Quintiles Japan to even greater levels of future success."
    Prior to SAP, Fujii was president of Cadence Design Systems, Japan, from
1997 to 2000.  Cadence is the world's leading supplier of electronic design
automation software and services.  Fujii successfully led Cadence's
diversification from product-centric businesses to the services area.  Fujii
also has an extensive and unique background in investment banking and
management consulting.
    After graduating in 1980 with a law degree from the University of Tokyo,
Fujii began his international business career with the consulting firm
McKinsey & Company as the first hire from a Japanese college when consulting
was little known in Japan.
    Then, Fujii earned his MBA from Harvard University in 1986 and joined CS
First Boston's M&A group in New York as one of the first Japanese M&A
investment bankers on Wall Street where he worked on many takeover defense,
LBO and recapitalization transactions.   From 1990 to 1993, he was director of
M&A Group at CS First Boston based in Tokyo where he led many Japanese
companies' acquisitions overseas.  In 1993, Fujji rejoined the management
consulting industry as a partner with Booz, Allen & Hamilton in charge of
strategy development practice for multinational companies in Japan.
    Quintiles helps improve healthcare worldwide by providing a broad range of
professional services, information and partnering solutions to the
pharmaceutical, biotechnology and healthcare industries.  Headquartered near
Research Triangle Park, North Carolina, Quintiles has offices in more than 50
countries and is the world's largest pharmaceutical services organization.
For more information visit the company's Web site at http://www.quintiles.com.


SOURCE Quintiles Transnational Corp.




Back to Topback to top

Related links:
  • http://www.quintiles.com
    CONTACT:
    Pat Grebe, Media Relations, +1-919-998-2091,
    or media.info@quintiles.com, or Greg Connors, Investor Relations,
    +1-919-998-2000, or invest@quintiles.com, both of Quintiles
    Transnational Corp.
    NOTE TO EDITORS: A photo of Kiyotaka Fujii is available. Contact
    Jay Johnson at 919-998-2066 or via email at
    jay.johnson@quintiles.com to request the .jpg photo.